AU2002357871A1 - High throughput correlation of polymorphic forms with multiple phenotypes within clinical populations - Google Patents

High throughput correlation of polymorphic forms with multiple phenotypes within clinical populations

Info

Publication number
AU2002357871A1
AU2002357871A1 AU2002357871A AU2002357871A AU2002357871A1 AU 2002357871 A1 AU2002357871 A1 AU 2002357871A1 AU 2002357871 A AU2002357871 A AU 2002357871A AU 2002357871 A AU2002357871 A AU 2002357871A AU 2002357871 A1 AU2002357871 A1 AU 2002357871A1
Authority
AU
Australia
Prior art keywords
high throughput
polymorphic forms
throughput correlation
multiple phenotypes
clinical populations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357871A
Inventor
Allen D. Roses
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU2002357871A1 publication Critical patent/AU2002357871A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/40—Population genetics; Linkage disequilibrium
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
AU2002357871A 2001-12-21 2002-12-18 High throughput correlation of polymorphic forms with multiple phenotypes within clinical populations Abandoned AU2002357871A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34489201P 2001-12-21 2001-12-21
US60/344,892 2001-12-21
PCT/US2002/040358 WO2003056328A1 (en) 2001-12-21 2002-12-18 High throughput correlation of polymorphic forms with multiple phenotypes within clinical populations

Publications (1)

Publication Number Publication Date
AU2002357871A1 true AU2002357871A1 (en) 2003-07-15

Family

ID=23352518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002357871A Abandoned AU2002357871A1 (en) 2001-12-21 2002-12-18 High throughput correlation of polymorphic forms with multiple phenotypes within clinical populations

Country Status (2)

Country Link
AU (1) AU2002357871A1 (en)
WO (1) WO2003056328A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1954832A4 (en) * 2005-12-06 2009-10-28 Gen Hospital Corp Diagnostic methods for pain sensitivity and chronicity and for tetrahydrobiopterin-related disorders
EP2488667A4 (en) * 2009-10-12 2013-07-10 Medimmune Llc Quantification of ir-a and ir-b for tumor classification

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030721A1 (en) * 1997-01-10 1998-07-16 Pioneer Hi-Bred International, Inc. Hybridization-based genetic amplification and analysis
US20010034023A1 (en) * 1999-04-26 2001-10-25 Stanton Vincent P. Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
DE1233365T1 (en) * 1999-06-25 2003-03-20 Genaissance Pharmaceuticals Method for producing and using haplotype data
WO2001027857A2 (en) * 1999-10-13 2001-04-19 Sequenom, Inc. Methods for generating databases and databases for identifying polymorphic genetic markers
WO2001077388A2 (en) * 2000-04-05 2001-10-18 Glaxo Group Limited Iterative analysis of non-responding population in the design of pharmacogenetic studies
US6475736B1 (en) * 2000-05-23 2002-11-05 Variagenics, Inc. Methods for genetic analysis of DNA using biased amplification of polymorphic sites
US6732648B1 (en) * 2003-05-05 2004-05-11 Day International Inc. Printing blanket sleeve having sound dampening feature

Also Published As

Publication number Publication date
WO2003056328A1 (en) 2003-07-10

Similar Documents

Publication Publication Date Title
AU785425C (en) Methods of genomic analysis
IL162170A0 (en) Labelled nucleotides
AU2003218283A1 (en) New fluorescence based biosensor
AU2003282713A1 (en) Microvolume embryo transfer system
AU2002217660A1 (en) Substrate for fluorescence analysis
AU2002331831A1 (en) Compounds and methods for fluorescent labeling
AU2003281311A1 (en) Fluorescent probe
AU2003257786A1 (en) Process for the preparation of 4, 1', 6'-trichloro-4, 1', 6'-trideoxygalactosucrose
AU2003281693A1 (en) Functional fluorescent dyes
AU2003251051A1 (en) Mounting of tubes
AU2003273640A1 (en) Autism gene
AU2002357871A1 (en) High throughput correlation of polymorphic forms with multiple phenotypes within clinical populations
AU2002331234A1 (en) Measurement of batch properties
AU2003293693A1 (en) Process for the preparation of bisphenols
AU2002354255A1 (en) Mtehod of analyzing gene expression
AU2002324845A1 (en) Methods for identifying heterozygous carriers of autosomal recessive diseases
AU2002251686A1 (en) Haplotypes of the CYP27B1 gene
AU2002368536A1 (en) Method of identifying nucleotide polymorphism
AUPR799601A0 (en) Sex specific gene
AU2002328863A1 (en) Oncosuppressive gene
AU2001294862A1 (en) Haplotypes of the sstr4 gene
AU2002249797A1 (en) Haplotypes of the tacr2 gene
AU2002251227A1 (en) Method for determining nucleotide mismatches
AU2001230640A1 (en) Multitemperature single strand conformation polymorphism (msscp)
AU2001248783A1 (en) Hybridization probes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase